Pseudoanguillosporin A (CAS 1159392-22-9)

Pseudoanguillosporin A is a secondary metabolite isolated from fungal sources, specifically marine-derived fungi, and is known for its unique structural features and biological activities. The compound is characterized by a bicyclic core structure with several oxygenated functional groups, which contribute to its reactivity and biological interactions. Pseudoanguillosporin A′s mechanism of action is not entirely explaind, but it is believed to interfere with cellular processes by binding to proteins or enzymes, potentially disrupting their normal function. In scientific research, Pseudoanguillosporin A is studied for its antimicrobial properties. It has shown activity against various bacterial and fungal pathogens, making it a subject of interest in the search for new antimicrobial agents. Researchers explore its efficacy in inhibiting the growth of resistant microbial strains, aiming to understand how it can be integrated into broader antimicrobial strategies. Additionally, Pseudoanguillosporin A is investigated for its cytotoxic effects on cancer cell lines. Studies focus on its ability to induce apoptosis and inhibit cell proliferation, providing insights into its potential mechanisms of action at the molecular level. This research contributes to a better understanding of how natural compounds can interact with cellular pathways to exert cytotoxic effects. Through these applications, Pseudoanguillosporin A aids in the exploration of novel antimicrobial and anticancer agents, highlighting the potential of marine-derived natural products in advancing biomedical research.